Ambu A/S (AMBU-B) - Net Assets
Based on the latest financial reports, Ambu A/S (AMBU-B) has net assets worth Dkr6.04 Billion DKK (≈ $944.38 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr7.58 Billion ≈ $1.19 Billion USD) and total liabilities (Dkr1.54 Billion ≈ $241.73 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is Ambu A/S's balance sheet for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr6.04 Billion |
| % of Total Assets | 79.62% |
| Annual Growth Rate | 14.21% |
| 5-Year Change | 52.71% |
| 10-Year Change | 508.37% |
| Growth Volatility | 15.74 |
Ambu A/S - Net Assets Trend (2002–2025)
This chart illustrates how Ambu A/S's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see AMBU-B stock market capitalisation.
Annual Net Assets for Ambu A/S (2002–2025)
The table below shows the annual net assets of Ambu A/S from 2002 to 2025. Explore AMBU-B cash generation efficiency to assess how effectively this company generates cash.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | Dkr6.04 Billion ≈ $944.22 Million |
+7.88% |
| 2024-09-30 | Dkr5.59 Billion ≈ $875.22 Million |
+3.73% |
| 2023-09-30 | Dkr5.39 Billion ≈ $843.77 Million |
+26.57% |
| 2022-09-30 | Dkr4.26 Billion ≈ $666.66 Million |
+7.82% |
| 2021-09-30 | Dkr3.95 Billion ≈ $618.32 Million |
+66.61% |
| 2020-09-30 | Dkr2.37 Billion ≈ $371.12 Million |
+8.71% |
| 2019-09-30 | Dkr2.18 Billion ≈ $341.39 Million |
+15.94% |
| 2018-09-30 | Dkr1.88 Billion ≈ $294.45 Million |
+47.15% |
| 2017-09-30 | Dkr1.28 Billion ≈ $200.11 Million |
+28.93% |
| 2016-09-30 | Dkr992.00 Million ≈ $155.21 Million |
-4.25% |
| 2015-09-30 | Dkr1.04 Billion ≈ $162.09 Million |
+21.31% |
| 2014-09-30 | Dkr854.00 Million ≈ $133.61 Million |
+28.04% |
| 2013-09-30 | Dkr667.00 Million ≈ $104.36 Million |
-1.64% |
| 2012-09-30 | Dkr678.11 Million ≈ $106.09 Million |
+16.94% |
| 2011-09-30 | Dkr579.86 Million ≈ $90.72 Million |
+3.25% |
| 2010-09-30 | Dkr561.60 Million ≈ $87.87 Million |
+17.09% |
| 2009-09-30 | Dkr479.62 Million ≈ $75.04 Million |
+6.11% |
| 2008-09-30 | Dkr452.01 Million ≈ $70.72 Million |
+8.09% |
| 2007-09-30 | Dkr418.18 Million ≈ $65.43 Million |
+6.93% |
| 2006-09-30 | Dkr391.07 Million ≈ $61.19 Million |
+12.01% |
| 2005-09-30 | Dkr349.14 Million ≈ $54.63 Million |
+9.06% |
| 2004-09-30 | Dkr320.14 Million ≈ $50.09 Million |
+8.85% |
| 2003-09-30 | Dkr294.12 Million ≈ $46.02 Million |
+3.58% |
| 2002-09-30 | Dkr283.94 Million ≈ $44.43 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ambu A/S's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4999.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Dkr5.86 Billion | 97.17% |
| Common Stock | Dkr135.00 Million | 2.24% |
| Other Comprehensive Income | Dkr36.00 Million | 0.60% |
| Total Equity | Dkr6.04 Billion | 100.00% |
Ambu A/S Competitors by Market Cap
The table below lists competitors of Ambu A/S ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Iluka Resources Ltd
AU:ILU
|
$2.36 Billion |
|
Dave Inc
NASDAQ:DAVE
|
$2.37 Billion |
|
Liberty Live Holdings, Inc. Series A Liberty Live Group Common Stock
NASDAQ:LLYVA
|
$2.37 Billion |
|
Jiangsu Huahong Technology Co Ltd
SHE:002645
|
$2.37 Billion |
|
China Automotive Engineering Research Institute Co Ltd
SHG:601965
|
$2.36 Billion |
|
Wuxi Huaguang Boiler Co Ltd
SHG:600475
|
$2.36 Billion |
|
Wilh Wilhelmsen Holding ASA A
OL:WWI
|
$2.36 Billion |
|
Coface SA
PA:COFA
|
$2.36 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ambu A/S's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,594,000,000 to 6,035,000,000, a change of 441,000,000 (7.9%).
- Net income of 609,000,000 contributed positively to equity growth.
- Dividend payments of 101,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 211,000,000.
- Other factors increased equity by 144,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr609.00 Million | +10.09% |
| Dividends Paid | Dkr101.00 Million | -1.67% |
| Other Comprehensive Income | Dkr-211.00 Million | -3.5% |
| Other Changes | Dkr144.00 Million | +2.39% |
| Total Change | Dkr- | 7.88% |
Book Value vs Market Value Analysis
This analysis compares Ambu A/S's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.90x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 37.06x to 2.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-09-30 | Dkr1.77 | Dkr65.45 | x |
| 2003-09-30 | Dkr1.83 | Dkr65.45 | x |
| 2004-09-30 | Dkr1.93 | Dkr65.45 | x |
| 2005-09-30 | Dkr1.48 | Dkr65.45 | x |
| 2006-09-30 | Dkr1.67 | Dkr65.45 | x |
| 2007-09-30 | Dkr1.77 | Dkr65.45 | x |
| 2008-09-30 | Dkr1.92 | Dkr65.45 | x |
| 2009-09-30 | Dkr2.03 | Dkr65.45 | x |
| 2010-09-30 | Dkr2.37 | Dkr65.45 | x |
| 2011-09-30 | Dkr2.44 | Dkr65.45 | x |
| 2012-09-30 | Dkr2.83 | Dkr65.45 | x |
| 2013-09-30 | Dkr2.83 | Dkr65.45 | x |
| 2014-09-30 | Dkr3.52 | Dkr65.45 | x |
| 2015-09-30 | Dkr4.19 | Dkr65.45 | x |
| 2016-09-30 | Dkr4.07 | Dkr65.45 | x |
| 2017-09-30 | Dkr5.26 | Dkr65.45 | x |
| 2018-09-30 | Dkr7.60 | Dkr65.45 | x |
| 2019-09-30 | Dkr8.82 | Dkr65.45 | x |
| 2020-09-30 | Dkr9.57 | Dkr65.45 | x |
| 2021-09-30 | Dkr15.61 | Dkr65.45 | x |
| 2022-09-30 | Dkr16.75 | Dkr65.45 | x |
| 2023-09-30 | Dkr20.69 | Dkr65.45 | x |
| 2024-09-30 | Dkr20.95 | Dkr65.45 | x |
| 2025-09-30 | Dkr22.60 | Dkr65.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ambu A/S utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.09%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.09%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.27x
- Recent ROE (10.09%) is below the historical average (11.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 5.28% | 2.61% | 1.02x | 1.98x | Dkr-13.41 Million |
| 2003 | 8.84% | 4.59% | 1.02x | 1.89x | Dkr-3.40 Million |
| 2004 | 10.40% | 5.47% | 1.03x | 1.85x | Dkr1.27 Million |
| 2005 | 10.80% | 5.76% | 0.99x | 1.88x | Dkr2.78 Million |
| 2006 | 12.38% | 6.76% | 1.06x | 1.73x | Dkr9.31 Million |
| 2007 | 10.23% | 5.98% | 1.05x | 1.63x | Dkr959.10K |
| 2008 | 11.06% | 6.38% | 1.07x | 1.62x | Dkr4.81 Million |
| 2009 | 11.63% | 6.36% | 1.12x | 1.63x | Dkr7.80 Million |
| 2010 | 14.97% | 8.94% | 1.07x | 1.56x | Dkr27.90 Million |
| 2011 | 11.94% | 7.04% | 1.11x | 1.53x | Dkr11.23 Million |
| 2012 | 16.92% | 10.97% | 1.08x | 1.42x | Dkr46.90 Million |
| 2013 | 7.20% | 3.47% | 0.73x | 2.84x | Dkr-18.70 Million |
| 2014 | 17.68% | 9.53% | 0.77x | 2.40x | Dkr65.60 Million |
| 2015 | 14.67% | 8.05% | 0.84x | 2.18x | Dkr48.40 Million |
| 2016 | 25.20% | 12.00% | 0.88x | 2.39x | Dkr150.80 Million |
| 2017 | 23.53% | 12.78% | 0.94x | 1.95x | Dkr173.10 Million |
| 2018 | 17.91% | 12.93% | 0.62x | 2.25x | Dkr148.80 Million |
| 2019 | 14.53% | 11.24% | 0.62x | 2.09x | Dkr98.80 Million |
| 2020 | 10.16% | 6.76% | 0.72x | 2.08x | Dkr3.80 Million |
| 2021 | 6.25% | 6.15% | 0.70x | 1.45x | Dkr-148.20 Million |
| 2022 | 2.18% | 2.09% | 0.62x | 1.69x | Dkr-333.10 Million |
| 2023 | 3.12% | 3.52% | 0.70x | 1.27x | Dkr-371.30 Million |
| 2024 | 4.20% | 4.36% | 0.75x | 1.28x | Dkr-324.40 Million |
| 2025 | 10.09% | 10.09% | 0.79x | 1.27x | Dkr5.50 Million |
Industry Comparison
This section compares Ambu A/S's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,248,583,054
- Average return on equity (ROE) among peers: 19.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ambu A/S (AMBU-B) | Dkr6.04 Billion | 5.28% | 0.26x | $2.36 Billion |
| ChemoMetec A/S (CHEMM) | $73.01 Million | 24.95% | 0.56x | $887.61 Million |
| Demant A/S (DEMANT) | $756.47 Million | 104.51% | 2.82x | $6.90 Billion |
| GN Store Nord (GN) | $5.33 Billion | 13.79% | 0.68x | $2.27 Billion |
| Scandinavian Medical Solutions AS (SMSMED) | $74.45 Million | 16.42% | 1.20x | $12.95 Million |
| ViroGates A/S (VIRO) | $8.98 Million | -60.13% | 0.34x | $16.41 Million |
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more